Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)703-718
Number of pages16
JournalPharmacoeconomics (Print)
Volume31
Issue number8
DOIs
Publication statusPublished - 9 May 2013

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this